Enterotoxigenic Bacteroides fragilis: A bacterial promoter of colon oncogenesis
产肠毒素脆弱拟杆菌:结肠癌发生的细菌启动子
基本信息
- 批准号:8137121
- 负责人:
- 金额:$ 52.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-02 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAffectAgeAnaerobic BacteriaAnimal ModelBacteriaBacteroides fragilisCancer ControlCancer EtiologyCancer PatientCellsCessation of lifeChronicClinicalColitisColonColon CarcinomaColonic NeoplasmsCrohn&aposs diseaseDNA DamageDendritic CellsDetectionDevelopmentE-CadherinEpithelialEtiologyExposure toFecesFigs - dietaryFundingGene MutationGenesHelicobacter pyloriHomeostasisHumanImmuneImmune responseImmune systemIncidenceIndiumInflammatoryInflammatory Bowel DiseasesInterleukin-17LeadMalignant NeoplasmsMetalloproteasesModelingMorbidity - disease rateMucosal Immune ResponsesMusMutant Strains MiceNested Case-Control StudyOncogenicPathogenesisPathway interactionsPatientsPeptic UlcerPrevention approachPrevention therapyProductionPublic HealthRaceResearch DesignSerologic testsSignal TransductionSolidT-Lymphocyte SubsetsTestingTimeToxinTumor Suppressor ProteinsUlcerative ColitisUnited StatesWomanbasec-myc Genescarcinogenesiscolon carcinogenesisexperiencemalignant stomach neoplasmmenmicrobialmortalitynovel diagnosticsnovel therapeuticspathogenpromoterprotein Epublic health relevancerepositoryresponsesensorsexsocioeconomicstumortumorigenesis
项目摘要
DESCRIPTION (provided by applicant): We have identified a human colon anaerobic bacterium, enterotoxigenic Bacteroides fragilis (ETBF), as a candidate etiologic agent for colon cancer and our murine models of ETBF colonization delineate a potential procarcinogenic immune pathway that ETBF induce. Just as the understanding of peptic ulcer disease and ensuing stomach cancer was transformed by the discovery of H. pylori, we hypothesize that ETBF, by secreting the potent B. fragilis toxin (BFT), precipitate procarcinogenic mucosal immune responses, thereby promoting formation of colon cancer. Our model does not propose to alter existing mutational paradigms of colon cancer but rather proposes that ETBF colonization is an integral mechanism accounting for the accumulation of genetic mutations necessary for colon carcinogenesis. This proposal will study the relationship between colon colonization by ETBF in humans, specific colon immune responses and, ultimately, colon cancer. Defining a microbial etiology for colon cancer has key implications as colon cancer is a major public health problem being the second leading cause of cancer death in the United States in women and men. A significant correlation between any two of the studied variables - ETBF colonization, colon immune responses and colon cancer -- will substantively alter current paradigms for the pathogenesis, prevention and therapy of colon cancer.
PUBLIC HEALTH RELEVANCE: Colon cancer is the second leading cause of cancer death for women and men. Current approaches to prevention of colon cancer are cumbersome and underutilized due to their expense and inconvenience. This project proposes that colon cancer is triggered by a common stool bacterium called enterotoxigenic Bacteroides fragilis (ETBF) and will test whether detection of ETBF and/or the colon immune response to ETBF provide new, easier approaches to the prevention of the morbidity and mortality due to colon cancer.
描述(由申请人提供):我们已经确定了一种人类结肠厌氧细菌,产肠毒素的脆弱拟杆菌(ETBF),作为结肠癌的候选病原,我们的ETBF定植的小鼠模型描绘了ETBF诱导的潜在的致癌前免疫途径。正如幽门螺杆菌的发现改变了对消化性溃疡疾病和随之而来的胃癌的认识一样,我们假设ETBF通过分泌强效的脆弱杆菌毒素(BFT),沉淀癌前黏膜免疫反应,从而促进结肠癌的形成。我们的模型并不建议改变现有的结肠癌突变模式,而是提出ETBF定殖是结肠癌发生所需的基因突变积累的完整机制。该提案将研究ETBF在人类结肠定殖,特定结肠免疫反应和最终结肠癌之间的关系。确定结肠癌的微生物病因具有重要意义,因为结肠癌是一个主要的公共卫生问题,是美国男性和女性癌症死亡的第二大原因。任何两个研究变量(ETBF定植、结肠免疫反应和结肠癌)之间的显著相关性将实质性地改变目前结肠癌发病机制、预防和治疗的范式。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(4)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DREW M. PARDOLL其他文献
DREW M. PARDOLL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DREW M. PARDOLL', 18)}}的其他基金
Role of YAP in Treg Function and YAP Targeting for Cancer Immunotherapy
YAP 在 Treg 功能中的作用和 YAP 靶向癌症免疫治疗
- 批准号:
10547779 - 财政年份:2018
- 资助金额:
$ 52.15万 - 项目类别:
Role of YAP in Treg Function and YAP Targeting for Cancer Immunotherapy
YAP 在 Treg 功能中的作用和 YAP 靶向癌症免疫治疗
- 批准号:
10330418 - 财政年份:2018
- 资助金额:
$ 52.15万 - 项目类别:
E3 ligase mediated control of Foxp3 expression and immune suppression-mechanisms and potential as immunotherapeutic target
E3连接酶介导的Foxp3表达和免疫抑制机制的控制以及作为免疫治疗靶点的潜力
- 批准号:
10331033 - 财政年份:2018
- 资助金额:
$ 52.15万 - 项目类别:
The Role of EOS in Regulatory T-cell Biology.
EOS 在调节性 T 细胞生物学中的作用。
- 批准号:
8490291 - 财政年份:2010
- 资助金额:
$ 52.15万 - 项目类别:
Mechanisms of TH17 Inflammation-Induced Colon Carcihogenesis
TH17炎症诱导的结肠癌发生机制
- 批准号:
8657874 - 财政年份:2010
- 资助金额:
$ 52.15万 - 项目类别:
The Role of EOS in Regulatory T-cell Biology.
EOS 在调节性 T 细胞生物学中的作用。
- 批准号:
8683077 - 财政年份:2010
- 资助金额:
$ 52.15万 - 项目类别:
Mechanisms of TH17 Inflammation-Induced Colon Carcihogenesis
TH17炎症诱导的结肠癌发生机制
- 批准号:
8105255 - 财政年份:2010
- 资助金额:
$ 52.15万 - 项目类别:
Enterotoxigenic Bacteroides fragilis: A bacterial promoter of colon oncogenesis
产肠毒素脆弱拟杆菌:结肠癌发生的细菌启动子
- 批准号:
8707985 - 财政年份:2010
- 资助金额:
$ 52.15万 - 项目类别:
PD-1/PD-L1 modulation in cancer therapy
癌症治疗中的 PD-1/PD-L1 调节
- 批准号:
10355495 - 财政年份:2010
- 资助金额:
$ 52.15万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 52.15万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 52.15万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 52.15万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 52.15万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 52.15万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 52.15万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 52.15万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 52.15万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 52.15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 52.15万 - 项目类别:
Operating Grants